- Home
- ICU vs GSIW Comparison
ICU vs GSIW Comparison
Compare ICU & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- GSIW
- Stock Information
- Founded
- ICU 2018
- GSIW 2016
- Country
- ICU United States
- GSIW Hong Kong
- Employees
- ICU N/A
- GSIW N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- ICU Health Care
- GSIW
- Exchange
- ICU Nasdaq
- GSIW Nasdaq
- Market Cap
- ICU 8.9M
- GSIW 8.6M
- IPO Year
- ICU N/A
- GSIW 2023
- Fundamental
- Price
- ICU $1.75
- GSIW $0.65
- Analyst Decision
- ICU
- GSIW
- Analyst Count
- ICU 0
- GSIW 0
- Target Price
- ICU N/A
- GSIW N/A
- AVG Volume (30 Days)
- ICU 24.8K
- GSIW 187.0K
- Earning Date
- ICU 11-13-2024
- GSIW 12-31-2024
- Dividend Yield
- ICU N/A
- GSIW N/A
- EPS Growth
- ICU N/A
- GSIW N/A
- EPS
- ICU N/A
- GSIW N/A
- Revenue
- ICU $68,000.00
- GSIW $1,408,469.00
- Revenue This Year
- ICU N/A
- GSIW N/A
- Revenue Next Year
- ICU $358.72
- GSIW N/A
- P/E Ratio
- ICU N/A
- GSIW N/A
- Revenue Growth
- ICU N/A
- GSIW N/A
- 52 Week Low
- ICU $1.68
- GSIW $0.52
- 52 Week High
- ICU $42.93
- GSIW $15.99
- Technical
- Relative Strength Index (RSI)
- ICU 34.18
- GSIW 49.06
- Support Level
- ICU $1.68
- GSIW $0.55
- Resistance Level
- ICU $2.01
- GSIW $0.69
- Average True Range (ATR)
- ICU 0.13
- GSIW 0.07
- MACD
- ICU -0.01
- GSIW 0.02
- Stochastic Oscillator
- ICU 14.00
- GSIW 56.55
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.